534 related articles for article (PubMed ID: 26850415)
1. Serum levels of the bone turnover markers dickkopf-1, sclerostin, osteoprotegerin, osteopontin, osteocalcin and 25-hydroxyvitamin D in Swedish geriatric patients aged 75 years or older with a fresh hip fracture and in healthy controls.
Wanby P; Nobin R; Von SP; Brudin L; Carlsson M
J Endocrinol Invest; 2016 Aug; 39(8):855-63. PubMed ID: 26850415
[TBL] [Abstract][Full Text] [Related]
2. Circulating levels of dickkopf-1, osteoprotegerin and sclerostin are higher in old compared with young men and women and positively associated with whole-body bone mineral density in older adults.
Coulson J; Bagley L; Barnouin Y; Bradburn S; Butler-Browne G; Gapeyeva H; Hogrel JY; Maden-Wilkinson T; Maier AB; Meskers C; Murgatroyd C; Narici M; Pääsuke M; Sassano L; Sipilä S; Al-Shanti N; Stenroth L; Jones DA; McPhee JS
Osteoporos Int; 2017 Sep; 28(9):2683-2689. PubMed ID: 28585053
[TBL] [Abstract][Full Text] [Related]
3. Alterations in bone turnover markers in patients with noncardio-embolic ischemic stroke.
Mathold K; Wanby P; Brudin L; Von SP; Carlsson M
PLoS One; 2018; 13(11):e0207348. PubMed ID: 30496210
[TBL] [Abstract][Full Text] [Related]
4. Assessment of Serum sRANKL, sRANKL/OPG Ratio, and Other Bone Turnover Markers with the Estimated 10-Year Risk of Major and Hip Osteoporotic Fractures in Rheumatoid Arthritis: A Cross-Sectional Study.
Nava-Valdivia CA; Ponce-Guarneros JM; Saldaña-Cruz AM; Corona-Sanchez EG; Ramirez-Villafaña M; Perez-Guerrero EE; Murillo-Saich JD; Contreras-Haro B; Vazquez-Villegas ML; Gonzalez-Ponce F; Bonilla-Lara D; Jacobo-Cuevas H; Centeno-Valadez JD; Echeverria-Gonzalez G; Cerpa-Cruz S; Alcaraz-Lopez MF; Cardona-Muñoz EG; Salazar-Paramo M; Gonzalez-Lopez L; Gamez-Nava JI
Biomed Res Int; 2021; 2021():5567666. PubMed ID: 34497849
[TBL] [Abstract][Full Text] [Related]
5. Correlation of blood bone turnover biomarkers and Wnt signaling antagonists with AS, DISH, OPLL, and OYL.
Niu CC; Lin SS; Yuan LJ; Chen LH; Yang CY; Chung AN; Lu ML; Tsai TT; Lai PL; Chen WJ
BMC Musculoskelet Disord; 2017 Feb; 18(1):61. PubMed ID: 28153008
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of sclerostin and dickkopf-1: effects of age, gender and fracture status.
Dovjak P; Dorfer S; Föger-Samwald U; Kudlacek S; Marculescu R; Pietschmann P
Gerontology; 2014; 60(6):493-501. PubMed ID: 24943689
[TBL] [Abstract][Full Text] [Related]
7. Effect of aromatase inhibition on serum levels of sclerostin and dickkopf-1, bone turnover markers and bone mineral density in women with breast cancer.
Kyvernitakis I; Rachner TD; Urbschat A; Hars O; Hofbauer LC; Hadji P
J Cancer Res Clin Oncol; 2014 Oct; 140(10):1671-80. PubMed ID: 24903965
[TBL] [Abstract][Full Text] [Related]
8. 25-Hydroxyvitamin-D and Bone Turnover Marker Levels in Patients with Distal Radial Fracture.
Rozental TD; Herder LM; Walley KC; Zurakowski D; Coyle K; Bouxsein ML; Wolf JM
J Bone Joint Surg Am; 2015 Oct; 97(20):1685-93. PubMed ID: 26491133
[TBL] [Abstract][Full Text] [Related]
9. Biomarkers and cytokines of bone turnover: extensive evaluation in a cohort of patients with ankylosing spondylitis.
Taylan A; Sari I; Akinci B; Bilge S; Kozaci D; Akar S; Colak A; Yalcin H; Gunay N; Akkoc N
BMC Musculoskelet Disord; 2012 Oct; 13():191. PubMed ID: 23025387
[TBL] [Abstract][Full Text] [Related]
10. Cystatin C as a potential predictor of osteoprotegerin levels in healthy men, a cross-sectional, observational study.
Kulcsar-Jakab E; Petho Z; Pap Z; Kalina E; Foldesi R; Balogh A; Antal-Szalmas P; Bhattoa HP
BMC Musculoskelet Disord; 2015 Aug; 16():227. PubMed ID: 26311162
[TBL] [Abstract][Full Text] [Related]
11. The levels of bone turnover markers 25(OH)D and PTH and their relationship with bone mineral density in postmenopausal women in a suburban district in China.
Gao C; Qiao J; Li SS; Yu WJ; He JW; Fu WZ; Zhang ZL
Osteoporos Int; 2017 Jan; 28(1):211-218. PubMed ID: 27468899
[TBL] [Abstract][Full Text] [Related]
12. Associations of vitamin D status with bone mineral density, bone turnover, bone loss and fracture risk in healthy postmenopausal women. The OFELY study.
Garnero P; Munoz F; Sornay-Rendu E; Delmas PD
Bone; 2007 Mar; 40(3):716-22. PubMed ID: 17112798
[TBL] [Abstract][Full Text] [Related]
13. Higher levels of s-RANKL and osteoprotegerin in children and adolescents with type 1 diabetes mellitus may indicate increased osteoclast signaling and predisposition to lower bone mass: a multivariate cross-sectional analysis.
Tsentidis C; Gourgiotis D; Kossiva L; Doulgeraki A; Marmarinos A; Galli-Tsinopoulou A; Karavanaki K
Osteoporos Int; 2016 Apr; 27(4):1631-1643. PubMed ID: 26588909
[TBL] [Abstract][Full Text] [Related]
14. Vitamin K1 and 25(OH)D are independently and synergistically associated with a risk for hip fracture in an elderly population: a case control study.
Torbergsen AC; Watne LO; Wyller TB; Frihagen F; Strømsøe K; Bøhmer T; Mowe M
Clin Nutr; 2015 Feb; 34(1):101-6. PubMed ID: 24559841
[TBL] [Abstract][Full Text] [Related]
15. Osteoprotegerin and sclerostin in chronic kidney disease prior to dialysis: potential partners in vascular calcifications.
Morena M; Jaussent I; Dupuy AM; Bargnoux AS; Kuster N; Chenine L; Leray-Moragues H; Klouche K; Vernhet H; Canaud B; Cristol JP
Nephrol Dial Transplant; 2015 Aug; 30(8):1345-56. PubMed ID: 25854266
[TBL] [Abstract][Full Text] [Related]
16. Role of Wnt/β-catenin and RANKL/OPG in bone healing of diabetic Charcot arthropathy patients.
Folestad A; Ålund M; Asteberg S; Fowelin J; Aurell Y; Göthlin J; Cassuto J
Acta Orthop; 2015; 86(4):415-25. PubMed ID: 25811776
[TBL] [Abstract][Full Text] [Related]
17. Potential Role of Bone Metabolism Markers in Kidney Transplant Recipients.
Vigil FMB; Vaz de Castro PAS; Hasparyk UG; Bartolomei VS; Simões E Silva AC
Curr Med Chem; 2024; 31(19):2809-2820. PubMed ID: 38332694
[TBL] [Abstract][Full Text] [Related]
18. The role of sclerostin/dickkopf-1 and receptor activator of nuclear factor kB ligand/osteoprotegerin signalling pathways in the development of osteoporosis in patients with haemophilia A and B: A cross-sectional study.
Anagnostis P; Vakalopoulou S; Christoulas D; Paschou SA; Papatheodorou A; Garipidou V; Kokkoris P; Terpos E
Haemophilia; 2018 Mar; 24(2):316-322. PubMed ID: 29194852
[TBL] [Abstract][Full Text] [Related]
19. Association of serum sclerostin with bone mineral density, bone turnover, steroid and parathyroid hormones, and fracture risk in postmenopausal women: the OFELY study.
Garnero P; Sornay-Rendu E; Munoz F; Borel O; Chapurlat RD
Osteoporos Int; 2013 Feb; 24(2):489-94. PubMed ID: 22525978
[TBL] [Abstract][Full Text] [Related]
20. Investigation of the relationship between serum sclerostin and dickkopf-1 protein levels with bone turnover in children and adolescents with type-1 diabetes mellitus.
Kurban S; Selver Eklioglu B; Selver MB
J Pediatr Endocrinol Metab; 2022 May; 35(5):673-679. PubMed ID: 35411762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
